For example, nystagmus associated with episodic ataxia type 2 caused by CACNA1A pathogenic variant can be ameliorated with acetazolamide, and Leber congenital amaurosis caused by bi-allelic RPE65 variants can be treated with gene therapy [45,46]. Here, CACNA1A is linked to episodic ataxia type 2.